BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cardiovascular Disorder (misc) News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
InterMune, Inc. Grabs FDA Breakthough Therapy Designation For IPF Drug Pirfenidone     7/18/2014
GlaxoSmithKline, Theravance, Inc. Begin Pivotal Phase 3 Trial For Triple Combination Treatment     7/16/2014
Bay Area's IMPAX Laboratories, Inc. Get Subpoena In Price Fixing Probe     7/16/2014
Abbott Laboratories Unloads Developed Markets Generics Unit To Mylan Inc. For $5.3 Billion     7/14/2014
Merck & Co., Inc.'s Januvia Linked To Increase In Heart Failure Hospitalizations     7/8/2014
GlaxoSmithKline To Invest $216 Million In New Factories, R&D     3/31/2014
FDA Panel To Weigh Painkiller' Cardiac Risk     2/10/2014
GlaxoSmithKline Heart Drug Misses Goal In Major Study     11/13/2013
EU Agency Questions AstraZeneca PLC Over Heart Drug Trial     11/8/2013
Merck & Co., Inc. Heart Drug Runs Into New Worry     10/24/2013
Alnylam Pharmaceuticals's Gene Therapy Shows Strong Efficacy Data in Phase 1 Study     9/24/2013
Bayer AG Grabs Approval for Adempas® as First Drug to Treat Rare Heart and Lung Disease     9/24/2013
AstraZeneca PLC Looks for New Heart Drug Approval by Next May     9/18/2013
Regado Biosciences, Inc. Kicks Off Big Clinical Trial for Heart Drug     9/17/2013
Sequestration Saps 40% of Framingham Heart Study's Budget     9/10/2013
 Featured Stories
Eating Lean Beef Daily Can Help Lower Blood Pressure, Penn State University Study     7/21/2014
Cholesterol-Lowering Drugs May Reduce Cardiovascular Death In Type 2 Diabetes, Wake Forest University Baptist Medical Center Study     7/18/2014
Facial Expressions May Reveal Health Status: Inability To Register Surprise Linked To Serious Heart Conditions, Carolinas Medical Center Study     7/15/2014
"Asian Glow" When Drinking May Keep Your Heart Healthy, British Medical Journal Reveals     7/14/2014
Why Dark Chocolate, Not Milk Chocolate May Make Walking Easier, Sapienza University Study     7/7/2014
Eating Almonds May Reduce Heart Disease Risk, Aston University     7/2/2014
Sex Hormone Levels At Midlife Linked To Heart Disease Risk In Women, University of Pittsburgh Study     7/1/2014
Too Much TV Linked To Early Death, University of Navarra Study     6/26/2014
Why Meat And Protein Are Not Really The Same     6/18/2014
Researchers Uncover Common Heart Drug's Link To Diabetes, McMaster University Study     6/13/2014
Poor Cardiovascular Health Linked To Memory, Learning Deficits, Brigham Young University Study     6/12/2014
Tomato Pill Could Prevent Heart Attacks, Fight Heart Disease, University of Cambridge Study     6/10/2014
Low-Carb Vegan Diet Helps Shed Weight, Lower Heart Disease Risk, St. Michael's Hospital Study     5/28/2014
Not Just For The Heart, Red Wine Shows Promise As Cavity Fighter, American Chemical Society Reveals     5/22/2014
How A Drug Can Slow Aging, Related Diseases, Oregon State University Study     5/22/2014
 More News
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a)     7/17/2014
Diabacor™ Discusses The Link Between Cardiovascular Disease And Diabetes     7/17/2014
Capricor Therapeutics, Inc. Announces Encouraging Results From Phase1 ALLSTAR Trial; Phase 2 Trial Underway     7/16/2014
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: New Report: Thymosin ?4 Prevents Heart Rupture & Improves Cardiac Function After Heart Attack In Mice     7/15/2014
The Medicines Company (MDCO) Receives Market Authorization Renewal For Angiox® (Bivalirudin) From The European Medicines Agency And The European Commission     7/7/2014
Ardelyx Inc. (ARDX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares     6/25/2014
LipoScience, Inc. Release: Study Published In Atherosclerosis Provides First Large-Scale, Real-World Evidence Of Link Between Low LDL Particle Levels And Reduced Risk Of Cardiovascular Disease     6/24/2014
Servier And miRagen Therapeutics Extend Collaboration For The Research, Development And Commercialization Of Microrna-Targeting Drugs For Cardiovascular Disease     6/23/2014
Boehringer Ingelheim Corporation Initiates RE-CIRCUIT™ Trial, Evaluating Pradaxa® (dabigatran etexilate mesylate) In NVAF Patients Undergoing Ablation     6/20/2014
Cardiome Pharma Corp. (COM.TO) To Present At JMP Securities Healthcare Investor Conference     6/20/2014
La Jolla Institute for Allergy and Immunology Advances Research Toward World's First Vaccine For Heart Disease     6/18/2014
Biopas And moksha8 Announce Strategic Alliance To Commercialize Specialty Pharmaceuticals Across Latin America     6/16/2014
BioXcel Expands PharmGPS™ Platform To Facilitate The Design Of Orphan Disease Treatments     6/12/2014
Oxygen Biotherapeutics, Inc. (OXBT) Announces Formation Of Steering Committee For Phase 3 LEVO-CTS Trial Of Levosimendan     6/2/2014
AtheroNova Inc. (AHRO.OB) Announces Russian Ministry Of Healthcare Approval For Initiation Of Phase 1b Trial Investigating AHRO-001     5/28/2014